Special Report: Easing the Painful Cost of Arthritis

Information is power in lightening the personal and financial toll of prescription drug costs.

Remarkable advancements have been made with the advent of biologic drugs to treat inflammatory arthritis, but some health insurance companies are now placing these medications into specialty tiers that require patients to pay 20 to 50 percent of drug costs.
To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Arthritis Advisor

Get the next year of Arthritis Advisor for just $20. And access all of our online content - over 1,000 articles - free of charge.
Subscribe today and save 36%. It's like getting 4 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access